IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Organicell Regenerative Medecine, Inc.

CUSIP: 68621D107 | 3 institutional holders

Quarters

Q3 2023Q2 2023Q4 2022Q3 2022Q4 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

Mathes Company, Inc.30,000
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Mathes Company, Inc.
30,000$10.0%CoreVery LowNew York, NY2023-10-26